Latest filing published 30 Apr 2026 for Pharmala Biotech Holdings Inc..
No signal scores available.
Farnoud Kazemzadeh is a declared insider of Pharmala Biotech Holdings Inc., with filings sourced from SEDI. Over a trading history stretching from 1 October 2025 to 28 April 2026, the count stands at 3 filings.
Purchases make up the whole of the open-market record (2 purchases). No amount is published for 2 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2026: 2 purchases and no sales on the market.
The newest entry dates from 30 April 2026: an open-market purchase, in Pharmala Biotech Holdings Inc. Typically, a trade is published a median of 2 days after it takes place. That lag is the time during which only the insider knows about the trade. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations